泌尿系结石的治疗进展(2)
 |
| 第1页 |
参见附件(1429KB，2页)。
5.4 药物排石 药物排石治疗可用于治疗小的(<0.6 cm)无嵌顿输尿管结石和体外冲击波碎石术后的辅助治疗。颇受关注的排石药物有钙通道拮抗剂、类固醇药、α肾上腺素能阻断剂。
相信随着科技水平的不断发展,将会有更多和更为先进的内镜技术、体内碎石能量、取石设备和排石药物出现,这些都将使结石的微创治疗将更安全和有效,给患者带来福音。
参考文献
[1] MazzaliM,KipariT,et al.Osteopontina molecule for all seasons.QJM,2002,95(1):313.
[2] Gao B,Yasui T,et al.Association of osteopontin gene hap lotypes with nephrolithiasis.Kidney Int,2007,72(5):592598.
[3] Okada A,Nomura S,et al Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection.Urol Res,2007,35(2):8999.
[4] Mo L,Zhu XH,et al.TammHorsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation.Kidney Int,2004,66(3):159166.
[5] Chutipongtanate S,Nakagawa Y,et al.Identification of human urinary trefoil factor as a novel calcium oxalate crystal growth inhibitor.J Clin Invest,2005,115(12):361362.
[6] Gravina GL,Costa AM,et al.Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotrip sy of renal stones.Urology,2005,66:2428.
[7] Okada A,Nomura S,et al.Successful for mation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection. Urol Res,2007,35(2):8999.
[8] Mo L,Huang HY,et al.Tamm Horsfall protein is a critical renal defense factor p rotecting against calcium oxalate crystal formation.Kidney Int,2004,66(3):11591166 ......
您现在查看是摘要介绍页，详见PDF附件(1429KB，2页)。